Cargando…
Impact of COVID-19 pandemic on SLE: beyond the risk of infection
Autores principales: | Horisberger, Alice, Moi, Laura, Ribi, Camillo, Comte, Denis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223264/ https://www.ncbi.nlm.nih.gov/pubmed/32376774 http://dx.doi.org/10.1136/lupus-2020-000408 |
Ejemplares similares
-
Measurement of circulating CD21(−)CD27(−) B lymphocytes in SLE patients is associated with disease activity independently of conventional serological biomarkers
por: Horisberger, Alice, et al.
Publicado: (2022) -
Restoration of NK Cell Cytotoxic Function With Elotuzumab and Daratumumab Promotes Elimination of Circulating Plasma Cells in Patients With SLE
por: Humbel, Morgane, et al.
Publicado: (2021) -
Management of Beta-Lactam Antibiotics Allergy: A Real-Life Study
por: Iuliano, Sarah, et al.
Publicado: (2022) -
Long‐term outcomes in corticosteroid‐refractory Graves' orbitopathy treated with tocilizumab
por: Moi, Laura, et al.
Publicado: (2021) -
Worse cardiovascular and renal outcome in male SLE patients
por: Mihailovic, Jelena, et al.
Publicado: (2023)